First-Year Real-Life Experience with Intravitreal Faricimab for Refractory Neovascular Age-Related Macular Degeneration

<b>Background</b>: To evaluate the outcomes of intravitreal faricimab (IVF) for refractory neovascular age-related macular degeneration (nAMD) and investigate the impact of baseline optical coherence tomography, biomarkers for total IVF injections are needed. <b>Methods</b>: A retrospective analysis...

Descrición completa

Detalles Bibliográficos

Principais autores:	Wissam Aljundi, Loay Daas, Shady Suffo, Berthold Seitz, Alaa Din Abdin
Formato:	Artigo
Idioma:	Inglês
Publicado:	MDPI AG 2024-03-01
Series:	Pharmaceutics
Assuntos:	faricimab anti-VEGF Ang-2 age-related macular degeneration subretinal fluid
Acceso en liña:	https://www.mdpi.com/1999-4923/16/4/470
Tags:	Engadir etiqueta Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!